Atlas Trials

Systemic Myasthenia Gravis

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Systemic Myasthenia Gravis

RecordFirmDate
A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis (NCT04302103)RemeGen Co., Ltd.2020-07-07

Track Systemic Myasthenia Gravis automatically

Every clearance here is in the API, with alerts when new ones post.